| Trial ID: | L5022 |
| Source ID: | NCT00419302
|
| Associated Drug: |
Technosphere/Insulin
|
| Title: |
To Compare the Effect of Inhaled Insulin With Subcutaneously Injected Insulin in Subjects With Type 2 Diabetes Mellitus.
|
| Acronym: |
|
| Status: |
COMPLETED
|
| Study Results: |
NO
|
| Results: |
|
| Conditions: |
Diabetes Mellitus, Type 2
|
| Interventions: |
DRUG: Technosphere/Insulin
|
| Outcome Measures: |
Primary: Glycemic response to a meal challenge | Secondary: Serum insulin concentrations measured for Technosphere/Insulin administration and subcutaneous insulin administration across 13 time points over a 270 minute period|Safety variables
|
| Sponsor/Collaborators: |
Sponsor: Mannkind Corporation
|
| Gender: |
ALL
|
| Age: |
ADULT, OLDER_ADULT
|
| Phases: |
PHASE2
|
| Enrollment: |
16
|
| Study Type: |
INTERVENTIONAL
|
| Study Designs: |
Allocation: RANDOMIZED|Intervention Model: CROSSOVER|Masking: NONE|Primary Purpose: TREATMENT
|
| Start Date: |
2003-10
|
| Completion Date: |
2004-04
|
| Results First Posted: |
|
| Last Update Posted: |
2009-10-14
|
| Locations: |
Profil Institute for Metabolic Research, Hellersbergstr, D-41460, Germany
|
| URL: |
https://clinicaltrials.gov/show/NCT00419302
|
